First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia

Description

Serogroups B, C, W and Y cause most IMD cases in Australia. The highest incidence occurs in children under 5 years of age. A second peak occurs in adolescents and young adults, which is also the age of highest carriage prevalence of N. meningitidis. Program evaluation of vaccine effectiveness against IMD is important. 

 

Learning Outcomes

  • Explain key components of the review.
  • List main recommendations.
  • Recognise changes in management as a result of the review.

 

Authors: Helen S Marshall, Noel Lally, Louise Flood, Paddy Phillips

Article Type: Narrative review

 

Medical Journal of Australia
N/A
Reading: journal; textbook; book; literature review
1h : 0m
MBA: 1h : 0m
Infectious Diseases
Medical Practitioner, Medical Student, Doctor-in-Training, Non-Vocationally Registered, Pharmacist, Researcher, Retired, Specialist - Other, Specialist General Practitioner
You have to be logged in to see the content of this module.

Provided by

  • © 2024 AMA (WA)
  • doctorportal Learning
  • ABN: 65 630 316 942
  • 14 Stirling Highway, Nedlands WA 6009, Australia
  • PO Box 133, Nedlands WA 6009
  • E: enquiries@dplearning.com.au

doctorportal Learning respectfully acknowledges Aboriginal and Torres Strait Islander peoples as the first inhabitants of Australia. We respect the traditional owners of lands across Australia in which our members and staff work and live, and pay respect to their elders past, present and emerging.